Elevation Oncology Inc. Gains 47.81%
Fri, Jan 05, 2024 at 07:58 PM
Elevation Oncology Inc. (ELEV:NASDAQ) soared at $0.87, representing a gain of 47.8%. On Fri, Jan 05, 2024, ELEV:NASDAQ touched a New 2-Week High of $0.87. From Tue, Dec 26, 2023, the stock recorded 42.86% Up Days and 62.50% Green Days
About Elevation Oncology Inc. (ELEV:NASDAQ)
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.
Top 10 Gainers:
- Revelstone Capital Acquisition Corp. (RCAC:NASDAQ), 91.15%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 64.85%
- Banzai International, Inc. Class A Common Stock (BNZI:NASDAQ), 54.82%
- Safe and Green Development Corporation (SGD:NASDAQ), 49.26%
- Elevation Oncology Inc. (ELEV:NASDAQ), 47.81%
- Wearable Devices Ltd. (WLDS:NASDAQ), 34.75%
- Swvl Holdings Corp (SWVL:NASDAQ), 32.02%
- RiceBran Technologies (RIBT:NASDAQ), 31.71%
- SRAX, Inc. (SRAX:NASDAQ), 28.57%
- Aurora Mobile Limited (JG:NASDAQ), 28.44%